Deep Vein Thrombosis: Clinical Trials

279 trials for Deep Vein Thrombosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

158 completed, 50 unknown, 24 terminated, 20 recruiting. 92 Not applicable, 32 Phase 3, 27 Phase 4, 17 Phase 2, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable92Completed 49, Unknown 13, Terminated 9, Recruiting 8, Active not recruiting 6, Withdrawn 4, Not yet recruiting 2, Enrolling by invitation 1
Phase 332Completed 23, Unknown 4, Withdrawn 2, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 427Completed 13, Terminated 5, Unknown 5, Active not recruiting 2, Recruiting 1, Withdrawn 1
Phase 217Completed 11, Terminated 5, Unknown 1
Phase 15Completed 3, Terminated 2
Early Phase 14Completed 3, Recruiting 1

Follow Deep Vein Thrombosis: new trials by email Literature Review of Deep Vein Thrombosis trials Research Report on Deep Vein Thrombosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SAFELY RULING OUT DEEP VEIN THROMBOSIS IN PREGNANCY WITH THE LEFt SCORE AND TRIMESTER-ADJUSTED D-DIMER CUTOFFS (the PREG-DVT Study): A PROSPECTIVE COHORT STUDY.
D-dimer - Pregnancy Related, Deep Vein Thrombosis
Not applicableNot yet recruitingMarc Righini3302027-04-012026-10-21
PROfunda Femoris Vein Thrombosis Evaluation and Clearance to Improve Outcomes of Endovascular Treatment for Acute Iliofemoral Deep Vein Thrombosis
Endovascular treatment with profunda femoris vein thrombosis clearance (Endovascular treatment with PFV-TC), Percutaneous mechanical thrombectomy without profunda femoris vein thrombosis clearance (PMT without PFV-TC) - Deep Vein Thrombosis
Not applicableRecruitingRenJi Hospital1402026-06-242026-10-13
TRiP-cast Score Validation and Evaluation of Adherence to Preventive Anticoagulant Treatment in Patients With Lower Limb Trauma Requiring Immobilization
Low-Molecular-Weight Heparin (LMWH), Direct Oral Anticoagulants (DOACs), No Thromboprophylaxis Cohort - Lower Extremity Injuries, Venous Thromboembolism (VTE)
RecruitingUniversity of Monastir15002025-09-012026-10-07
The Effect of a VTE Prevention Care Bundle in Total Hip Arthroplasty Patients
VTE Prevention Care Bundle, Standard Routine Care - Venous Thromboembolism, Total Hip Arthroplasty (THA)
Not applicableActive not recruitingMurat Erten1102025-06-172026-07-14
Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study
Celect Platinum Vena Cava Filter - Deep Vein Thrombosis, Venous Thromboembolism
RecruitingCook Research Incorporated822025-06-022026-04-17
Timing of Thromboprophylaxis After Postpartum Hemorrhage
Pharmacologic Thromboprophylaxis - Postpartum Hemorrhage, Venous Thromboembolism
CompletedUniversity Tunis El Manar2362025-03-012026-07-08
Apixaban in Thrombocytopenia
Apixaban - Deep Vein Thrombosis, Pulmonary Embolism and Thrombosis
Early Phase 1RecruitingRushad Patell302025-02-282026-04-15
ClotTriever® Thrombectomy System Use-Result Survey in Japan
ClotTriever® Thrombectomy System - Deep Vein Thrombosis
Enrolling by invitationInari Medical1002025-02-172026-10-23
DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients
DOACT algorithm, No algorithm, LLM-based tools - Deep Vein Thrombosis, Superficial Thrombophlebitis
Not applicableCompletedITALO EUGENIO SOUZA GADELHA DE ABREU592025-01-202025-12-18
Microvisk Continuous Blood Donation Study
Venepuncture, Collection of relevant information - Pulmonary Embolism (Diagnosis), Deep Vein Thrombosis
Not applicableNot yet recruitingMicrovisk Technologies Ltd25002025-01-132024-11-21
Systematic Machine Learning Algorithm for Rapid Thrombosis Detection
POC D-dimer, POC ultrasound, Machine learning model - Deep Vein Thrombosis
Not applicableRecruitingOstfold Hospital Trust10002025-01-062025-02-26
Non-invasive Venous Air Plethysmography Assessment of Venous Hemodynamics in Patients Suspected Deep Venous Obstruction Used in Conjunction With Intermittent Pneumatic Compression.
Mayo Dopplex ABIlity, Intermittent Pneumatic Compression (IPC) - Deep Vein Thrombosis
RecruitingMayo Clinic5002024-11-152025-10-28
inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT
Short duration prophylaxis, Higher intensity and longer duration prophylaxis, Control - Venous Thromboembolism, Venous Thromboses
Phase 4RecruitingLeiden University Medical Center100782024-11-112026-09-08
A Multi-center Cohort Study for Conventional Ultrasound Image Set Collection to Create a Data Set for Research Purposes.
Deep Vein Thrombosis
RecruitingThrombUS+30002024-11-062025-05-25
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Immune Thrombocytopenia, Thrombotic Thrombocytopenic Purpura
RecruitingPeking University People's Hospital30002024-11-012024-12-11
Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage
Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting within the first 2 days but not earlier than 12 hours after a hospital admission., Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting on the 3rd day after a hospital admission. - Venous Thromboembolism, Pulmonary Embolism
Not applicableRecruitingPirogov Russian National Research Medical University2002024-10-212026-03-24
Emulation of the RECORD3 Trial Using Healthcare Claims Data
Rivaroxaban, Enoxaparin - Deep Vein Thrombosis, Pulmonary Embolus
CompletedBrigham and Women's Hospital1492482024-10-132026-07-10
RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing
Rivaroxaban 10 MG, Low Heparin Molecular Weight - Venous Thromboembolism, Deep Vein Thrombosis
Phase 3RecruitingUniversity Hospital, Angers14242024-07-192026-06-25
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
Exposure to clinical decision support system and education - Venous Thromboembolism, Pulmonary Embolism
Not applicableActive not recruitingMedical University of South Carolina302024-07-012026-09-09
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
EHR (electronic health record) alert, No EHR (electronic health record) alert - Venous Thromboembolic Disease, Pulmonary Embolism and Thrombosis
Not applicableUnknownScott C. Woller, MD1520002024-06-012024-07-17

Showing 20 of 279. Sign in to see all of them.

Narrower conditions

Venous Thrombosis (279)  ·  Pulmonary Embolism (127)  ·  Venous Thromboembolism (66)  ·  Thrombosis (36)  ·  Atrial Fibrillation (26)  ·  Postthrombotic Syndrome (20)  ·  Neoplasms (15)  ·  Thromboembolism (11)  ·  Stroke (9)  ·  Embolism and Thrombosis (7)  ·  Hemorrhage (6)  ·  Recurrence (6)  ·  Wounds and Injuries (6)  ·  COVID-19 (5)  ·  Heart Failure (5)

Broader conditions

Cardiovascular Diseases (276)  ·  Vascular Diseases (275)  ·  Embolism and Thrombosis (272)  ·  Thrombosis (243)  ·  Respiratory Tract Diseases (130)  ·  Lung Diseases (129)  ·  Embolism (123)  ·  Pathological Conditions, Signs and Symptoms (65)  ·  Pathologic Processes (64)  ·  Thromboembolism (61)  ·  Heart Diseases (36)  ·  Arrhythmias, Cardiac (26)  ·  Disease Attributes (20)  ·  Venous Insufficiency (19)  ·  Nervous System Diseases (17)

Interventions

Enoxaparin (20)  ·  Rivaroxaban (14)  ·  apixaban (14)  ·  Dalteparin (8)  ·  Heparin (8)  ·  Heparin, Low-Molecular-Weight (8)  ·  Tinzaparin (8)  ·  Warfarin (7)  ·  edoxaban (5)  ·  Blood Specimen Collection (4)  ·  Educational Status (3)  ·  Fondaparinux (3)  ·  Rosuvastatin Calcium (3)  ·  Standard of Care (3)  ·  Tissue Plasminogen Activator (3)

Sponsors

Brigham and Women's Hospital (11)  ·  Ottawa Hospital Research Institute (8)  ·  Intermountain Health Care, Inc. (5)  ·  Mayo Clinic (5)  ·  McMaster University (5)  ·  Bayer (4)  ·  BiO2 Medical (4)  ·  Bristol-Myers Squibb (4)  ·  Centre Hospitalier Universitaire de Nīmes (4)  ·  Leiden University Medical Center (4)  ·  RenJi Hospital (4)  ·  Azienda Ospedaliera Universitaria Policlinico (3)  ·  Hamilton Health Sciences Corporation (3)  ·  Imperial College London (3)  ·  Pirogov Russian National Research Medical University (3)

Countries

United States (87)  ·  France (34)  ·  Canada (33)  ·  United Kingdom (30)  ·  Italy (25)  ·  China (14)  ·  Germany (13)  ·  Netherlands (13)  ·  Israel (12)  ·  Switzerland (12)  ·  Brazil (11)  ·  Russia (10)  ·  Spain (10)  ·  Denmark (9)  ·  Australia (8)

Top investigators

Samuel Z Goldhaber, MD (4)  ·  Samuel Z. Goldhaber, MD (4)  ·  Marc Righini, MD (3)  ·  Sergio Siragusa, MD (3)  ·  Andrew McGovern, MD (2)  ·  Damon Houghton, MD (2)  ·  Jim Julian, MMath (2)  ·  Jorge Duconge, PhD (2)  ·  Leonella Pasqualini, MD (2)  ·  Marc Rodger, MD (2)  ·  Paolo Prandoni, MD, PhD (2)

Results publications

PMID 35570249, PMID 39968829, PMID 23279103, PMID 23306310, PMID 23629822, PMID 26867832, PMID 31630479, PMID 36044159, PMID 10737280, PMID 10963635, PMID 12393647, PMID 14715365, PMID 15344424, PMID 15809460, PMID 15992223, PMID 16458642, PMID 16926353, PMID 17065639, PMID 17289685, PMID 17635708, PMID 17635709, PMID 17855670, PMID 17855671, PMID 17940483, PMID 18219451, PMID 18433464, PMID 18497320, PMID 18664970, PMID 18725614, PMID 18840838, PMID 19078910, PMID 19228281, PMID 19333044, PMID 19348685, PMID 19364975, PMID 19414836, PMID 19422443, PMID 19657123, PMID 19718469, PMID 19817986, PMID 19965693, PMID 20047905, PMID 20084351, PMID 20124539, PMID 20206776, PMID 20352167, PMID 20553388, PMID 20561184, PMID 20669525, PMID 20694281

NIH funding

2015 (2), 2023 (2), 2004 (1), 2008 (1), 2016 (1), G12MD007600 (1), K23HL132054 (1), P30CA015083 (1), P30CA138313 (1), R01HL141900 (1), SC2HL110393 (1), U01HL088476 (1)